Medical Device
Manufacturing
THE TRADE PAPER OF THE FACTORY FLOOR
Z-2744-2018Class II

AbViser AutoValve IAP (intra- abdominal pressure) Monitoring Device, Patient mount: a) REF ABV300, b) REF...

ConvaTec Limited / initiated 2018-07-03 / Terminated / root cause: manufacturing process

ConvaTec, Inc began a recall of AbViser AutoValve IAP (intra- abdominal pressure) Monitoring Device, Patient mount: a) REF ABV300, b) REF ABV301 AbViser is a sterile non-invasive disposable... on . FDA classified it as Class II and gives the reason as "Bubble Leak Testing on AbViser AutoValve IAP Monitoring Devices without Transducer confirmed the potential for a pinhole breach in the sterile barrier". As of , the recall status on record is Terminated, and MDM tags the root cause as manufacturing process.

Recall record

Recall number
Z-2744-2018
Classification
Class II
Status
Terminated
Initiated
Posted
Terminated
Recalling firm
ConvaTec Limited
Product
AbViser AutoValve IAP (intra- abdominal pressure) Monitoring Device, Patient mount: a) REF ABV300, b) REF ABV301 AbViser is a sterile non-invasive disposable intra- abdominal pressure monitoring device containing aspiration tubing, infusion tubing, valves and optional pressure transducers for the measurement of intra- abdominal bladder pressure. The device attaches directly to the patient s existing urinary catheter/drain system providing both an enclosed fluid path for infusing fluid into the bladder catheter in order to monitor the hydrostatic pressure in the bladder.
Product code
FEN Device, Cystometric, Hydraulic
Reason for recall
Bubble Leak Testing on AbViser AutoValve IAP Monitoring Devices without Transducer confirmed the potential for a pinhole breach in the sterile barrier.
Root cause tag
manufacturing process
FDA root cause
Nonconforming Material/Component
Action
The firm, ConVaTec, sent an "URGENT: VOLUNTARY MEDICAL DEVICE RECALL" letter dated July 2, 2018, to its customers via United Parcel Service of America (UPS) Ground with tracking on July 3, 2018, with emails sent to distributors on July 9, 2018. The letter describes the product, problem and actions to be taken. The customers were instructed to do the following: 1. Inspect your inventory to confirm if you have any of the affected product codes. 2 Perform a count of affected product currently in inventory. Complete the enclosed response form and return it to the address on the response form. Return the attached Recall Response Form even if no affected product is in inventory. 3 If you have any affected product in inventory please contact [email protected] or call the Customer Interaction Center at the toll free number 1-800-422-8811. You will be provided further instructions regarding how to return affected product and arrange credit.
Quantity in commerce
3881 units
Distribution
worldwide Distribution: US (nationwide) and countries of: Australia, Austria, Canada, Bahrain, Bangladesh, Belgium, Chile, China, Colombia, Croatia, Czech Republic, Denmark, Estonia, Finland, France, Germany, Hungary, India, Israel, Italy, Kenya, Kuwait, Malta, Mauritius, Netherlands,Norway, Portugal, Qatar, Romania, Saudi Arabia, Singapore, Slovenia, South Africa, South Korea, Spain, Sweden, Switzerland, Taiwan, Turkey, United Kingdom, United Arab Emirates, and Vietnam.
Product codes and lots
a) ABV 300: Lot Number 150924 b) ABV 301: Lot Numbers: 160937, 161023, 161128, 170120, 170514, 170732, 170801, 170829

Enforcement reports

One row per recalled product line
FDA enforcement reports joined to recall event Z-2744-2018
Recall numberClassStatusVoluntary or mandatedReport dateClassified
Z-2744-2018Class IITerminatedVoluntary: Firm initiated